Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Escitalopram
smokers
use in patients with hepatic impairment
Esketamine, enantiomer of ketamine
Esketamine (intranasal)
Espranor ododispersible buprenorphine brand
Established treatments (listed in αbetical order)
estimated glomerular filtration rate (eGFR), renal impairment assessment
Estimated phenotype frequency by ancestry for CYP1A2, CYP2D6, CYP2C19, CYP2C9 and CYP3A4.
Evidence and experience regarding the pharmacological treatment of motor symptoms in Huntington's disease (HD)
Example protocols for transition from low-dose methadone to buprenorphine
Examples of common unlicensed uses of drugs in psychiatric practice
Excited delirium
Excretion of drugs, changes with old age
Excretory capacity of the kidney, estimation in renal impairment assessment
Expectations of treatment, placebo and nocebo effects
extended release (ER) preparations
intramuscular injections
memantine for older adults
extrapyramidal side effects (EPSEs)
amisulpride
children
features of most common symptoms
first generation antipsychotics
high-dose antipsychotics
methamphetamine use plus antipsychotics
patient sensitivity
people living with human immunodeficiency virus
people with learning difficulties
smoking alleviating symptoms
switching antipsychotics
treatment
Refresh
first
prev
1
2
30
select
next
last
Displaying items 31 - 46 of 46